Contact Us  |  Careers  |  Site Map             Home  >> ABOUT US   >> SCIENTIFIC ADVISORY BOARD   SCIENTIFIC ADVISORY BOARD Email a Friend | Print this Page Xcovery's distinguished SAB combines the talents of the leading biological scientists, medicinal chemists, and clinical experts to create a board that ensures that sound medical and scientific knowledge supports Xcovery’s drug development efforts in the field of kinase therapeutics. Dr. Sydney Brenner MD » Nobel Laureate, Medicine, 2008 » Director, Singapore Life Science Laboratory » Fellow of the Royal Society UK » Distinguished Research Professor, The Salk Institute Sir Philip Cohen FRS, FRSE » Director, University of Dundeee Scotland School of Life Sciences Research Biocentre » Royal Society Research Professor » Director, Medical research Council Protein Phosphrylation Unit » Research focus: Serine/threonine signaling expert Dr. Brian Druker MD » Director, Oregon Health & Science University Cancer Institute Leukemia Center » National Academy of Science » Developer of Gleevec, Novartis' small molecule therapeutic for cancers, including Chronic Myelogenous Leukemia and Gastrointestinal Stromal Tumors. » Howard Hughes Medical Institute Investigator » Research focus: Tyrosine kinase signaling expert Sir David Lane FRS, FRSE » University of Dundee College of Life Sciences » Chief Scientist, Cancer Research UK » Executive Director, Singapore Life Science Laboratory » Research focus: p53 tumor suppressor     Copyright Xcovery Website by Axxiem